Department of Medicine (III-0), Veterans Affairs Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA.
Eur J Vasc Endovasc Surg. 2012 Mar;43(3):254-6. doi: 10.1016/j.ejvs.2011.12.026. Epub 2012 Jan 9.
In a 1997 report of a large abdominal aortic aneurysm (AAA) screening study, we observed a negative association between diabetes and AAA. Although this was not previously described and negative associations between diseases are rare, the credibility of the finding was supported by consistent results in several previous studies and by the absence of an obvious artifactual explanation. Since that time, a variety of studies of AAA diagnosis, both by screening and prospective clinical follow-up, have confirmed the finding. Other studies have reported slower aneurysm enlargement and fewer repairs for rupture in diabetics. The seeming protective effect of diabetes for AAA contrasts with its causal role in occlusive vascular disease and so provides a strong challenge to the traditional view of AAA as a manifestation of atherosclerosis. Research focused on a protective effect of diabetes has already increased our understanding of the etiology of AAA, and might eventually pave the way for new therapies to slow AAA progression.
在 1997 年的一项大型腹主动脉瘤(AAA)筛查研究报告中,我们观察到糖尿病与 AAA 之间存在负相关关系。尽管这在此前并未被描述过,且疾病之间的负相关关系很少见,但该发现的可信度得到了几个先前研究中一致结果的支持,并且没有明显的人为解释。自那时以来,对 AAA 的各种诊断研究,包括通过筛查和前瞻性临床随访,都证实了这一发现。其他研究报告称,糖尿病患者的动脉瘤扩张速度较慢,破裂后修复的情况也较少。糖尿病对 AAA 的这种保护作用与它在闭塞性血管疾病中的因果作用形成鲜明对比,因此对 AAA 作为动脉粥样硬化表现的传统观点提出了强烈挑战。针对糖尿病的保护作用的研究已经增加了我们对 AAA 病因的理解,并且最终可能为减缓 AAA 进展的新疗法铺平道路。